Showing 491-500 of 1780 results for "".
Tracking Immune Activity in Severe Alopecia Areata
https://reachmd.com/programs/dermconsult/immune-activity-severe-alopecia-areata/49022/RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
https://reachmd.com/programs/neurofrontiers/raise-subgroup-analysis-zilucoplan/51013/Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
https://reachmd.com/programs/neurofrontiers/omaveloxolone-in-friedreichs-ataxia-early-real-world-signals/54666/ATTR-CM Trials Revisited: A Broader View of Treatment Benefit
https://reachmd.com/programs/heart-matters/attr-cm-trials-treatment-benefit/49050/Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
https://reachmd.com/programs/eye-on-ocular-health/time-to-recurrence-and-early-risk-indicators-in-brvo-related-macular-edema/54481/Guselkumab in Skin of Color: Results from a Randomized Phase 3b Psoriasis Trial
https://reachmd.com/programs/dermconsult/guselkumab-in-skin-of-color-results-from-a-randomized-phase-3b-psoriasis-trial/36371/Roflumilast Foam for Psoriasis: Efficacy, Tolerability, and Clinical Relevance
https://reachmd.com/programs/dermconsult/roflumilast-foam-for-psoriasis-efficacy-tolerability-and-clinical-relevance/36370/Women in Aesthetics: Fairyal Day
https://reachmd.com/topics/practice-development/women-in-aesthetics-fairyal-day/48886/Get to know Fairyal Day, Founder of Med Talent, Global Medical Search, an executive search firm specializing in the medical aesthetics, dermatology, dental, and pharmaceutical industriesClemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
https://reachmd.com/programs/neurofrontiers/clemastine-fumarate-and-progressive-ms-a-closer-look-at-unexpected-risks-and-mechanisms/32825/Examining Airway Tolerability of a Climate Conscious Inhaler
https://reachmd.com/programs/clinicians-roundtable/airway-tolerability-climate-conscious-inhaler/54178/